Recent developments in the field of antitumour anthracyclines

[1] New anthracycline disaccharides. Synthesis of L-daunosaminyl-alpha(1->4)-2-deoxy-L-rhamnosyl and of L-daunosaminyl-alpha(1->4)-2-deoxy-L-fucosyl daunorubicin analogues [J]. JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1996, (12): : 1327 - 1329

[2] Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model [J]. SCIENCE, 1998, 279 (5349) : 377 - 380

[3] New developments in antitumor anthracyclines [J]. PHARMACOLOGY & THERAPEUTICS, 1997, 76 (1-3) : 117 - 124

[4] ADRIAMYCIN, 14-HYDROXYDAUNOMYCIN, A NEW ANTITUMOR ANTIBIOTIC FROM S-PEUCETIUS VAR CAESIUS [J]. BIOTECHNOLOGY AND BIOENGINEERING, 1969, 11 (06) : 1101 - &

[5] Arcamone F, 1998, CURR MED CHEM, V5, P391

[6] ARCAMONE F, 1976, CANCER TREAT REP, V60, P829

[7] From the pigments of the actinomycetes to third generation antitumor anthracyclines [J]. BIOCHIMIE, 1998, 80 (03) : 201 - 206

[8] ANTIBODY DIRECTED ENZYMES REVIVE ANTICANCER PRODRUGS CONCEPT [J]. BRITISH JOURNAL OF CANCER, 1987, 56 (05) : 531 - 532

[9] A CYTO-TOXIC AGENT CAN BE GENERATED SELECTIVELY AT CANCER SITES [J]. BRITISH JOURNAL OF CANCER, 1988, 58 (06) : 700 - 703

[10] STABILIZATION OF CHIMERIC BR96-DOXORUBICIN IMMUNOCONJUGATE [J]. PHARMACEUTICAL RESEARCH, 1995, 12 (02) : 215 - 222

[1] New anthracycline disaccharides. Synthesis of L-daunosaminyl-alpha(1->4)-2-deoxy-L-rhamnosyl and of L-daunosaminyl-alpha(1->4)-2-deoxy-L-fucosyl daunorubicin analogues [J]. JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1996, (12): : 1327 - 1329

[2] Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model [J]. SCIENCE, 1998, 279 (5349) : 377 - 380

[3] New developments in antitumor anthracyclines [J]. PHARMACOLOGY & THERAPEUTICS, 1997, 76 (1-3) : 117 - 124

[4] ADRIAMYCIN, 14-HYDROXYDAUNOMYCIN, A NEW ANTITUMOR ANTIBIOTIC FROM S-PEUCETIUS VAR CAESIUS [J]. BIOTECHNOLOGY AND BIOENGINEERING, 1969, 11 (06) : 1101 - &

[5] Arcamone F, 1998, CURR MED CHEM, V5, P391

[6] ARCAMONE F, 1976, CANCER TREAT REP, V60, P829

[7] From the pigments of the actinomycetes to third generation antitumor anthracyclines [J]. BIOCHIMIE, 1998, 80 (03) : 201 - 206

[8] ANTIBODY DIRECTED ENZYMES REVIVE ANTICANCER PRODRUGS CONCEPT [J]. BRITISH JOURNAL OF CANCER, 1987, 56 (05) : 531 - 532

[9] A CYTO-TOXIC AGENT CAN BE GENERATED SELECTIVELY AT CANCER SITES [J]. BRITISH JOURNAL OF CANCER, 1988, 58 (06) : 700 - 703

[10] STABILIZATION OF CHIMERIC BR96-DOXORUBICIN IMMUNOCONJUGATE [J]. PHARMACEUTICAL RESEARCH, 1995, 12 (02) : 215 - 222